- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1180EUR$1,250USD£1,004GBP
- Drug Pipelines
- April 2024
- 250 Pages
Global
From €2833EUR$3,000USD£2,410GBP
- Report
- July 2024
- 73 Pages
Global
From €3500EUR$3,970USD£3,081GBP
- Report
- August 2022
- 68 Pages
Global
From €3305EUR$3,500USD£2,811GBP
The Retinoic Acid Receptor Alpha (RARα) market is a segment of the genomics industry that focuses on the development of products and services related to the RARα gene. RARα is a nuclear receptor that plays a role in the regulation of gene expression and is involved in a variety of biological processes, including cell differentiation, development, and metabolism. It is also involved in the regulation of the immune system and is a potential target for the development of new drugs.
The RARα market is composed of a variety of companies, including biotechnology and pharmaceutical companies, as well as research institutions and universities. Companies in the market are focused on developing products and services related to RARα, such as diagnostic tests, therapeutic drugs, and research tools. Examples of companies in the RARα market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Merck, Novartis, and Pfizer. Show Less Read more